Acute Graft versus host disease (aGVHD)
Acute GVHD is a potential complication following an allogeneic stem cell transplant, where donor immune cells (the graft) mistakenly attack the recipient’s healthy tissues (the host).
Common Areas Affected
Skin – Rash, redness, burning, or peeling. Often starts on the palms, soles, or trunk
Gastrointestinal tract – Nausea, vomiting, abdominal pain, diarrhea, or loss of appetite
Liver – Jaundice (yellowing of skin or eyes), abnormal liver function tests
Causes and Risk Factors: GVHD occurs when donor T cells recognize the recipient’s cells as foreign and begin attacking them.
Risk factors include:
HLA mismatch between donor and recipient
Older age (patient or donor)
Donor of a different sex, especially female donors for male recipients
Donor history of pregnancy
Treatment Options: Treatment is tailored based on severity and organ involvement. Ongoing monitoring is essential.
Immunosuppressive medications
Corticosteroids
Topical treatments
Biologic medications
What I Wish I Knew
GVHD can affect internal organs, not just the skin—ask for full-body symptom education
Symptoms may appear gradually or overlap with other conditions
It’s helpful to understand how GVHD presents differently in each person
Ask for links or visuals showing what skin or GI symptoms might look like
Questions to Ask
Is GVHD beneficial in fighting residual disease?
What are the early signs I should watch for?
How does GVHD differ from other post-transplant complications?
What are the treatment options if symptoms don’t respond to steroids?
Long term monitoring
Common Myths
Myth: “The longer you go, the safer you are and won't get GVHD”
Fact: Not always true. GVHD can develop later, and symptoms may be subtle at first.
Myth: “It only affects the skin”
Fact: GVHD can affect internal organs, and symptoms may not be visible
Helpful Tips
Speak up—even if the symptom feels small or vague
Keep a daily log of changes in skin, digestion, or energy levels
Ask for visuals or examples of what symptoms might look like
Don’t wait for symptoms to worsen before calling your care team
Disclaimer: This Journey Map is for educational purposes only. It does not provide medical advice, diagnosis, or treatment. Every patient’s situation is unique, and care decisions should always be made in consultation with your clinical team.
We extend our appreciation to Sanofi and Alexion for their generous partnership and active participation in our community. Their support helped bring patients, caregivers, clinicians, and industry partners together to co-create this Journey Map and improve the transplant experience.
Our Journey Map was created for Patients and Caregivers by Patients and Caregivers. Please share any corrections or additions!